Nadim Ednan-Laperouse
Comment & OpinionHow our new Natasha Ednan-Laperouse Clinical Trial could save lives and help eradicate food allergies
The £2.2m Natasha Clinical Trial is about helping to protect the millions of people in the UK with food allergies from allergic reactions, says Nadim Ednan-Laperouse
Comment & OpinionAllergen labelling: is the food industry really willing to endanger lives?
Businesses must put consumers’ safety ahead of a possible (and, at worst, tiny) dent in profit, says Natasha Ednan-Laperouse’s father